v3.25.1
Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Income Statement [Abstract]    
Revenue from collaboration agreements $ 7,238 $ 3,039
Operating expenses:    
Research and development 27,072 22,533
General and administrative 9,330 10,288
Restructuring 0 2,437
Total operating expenses 36,402 35,258
Loss from operations (29,164) (32,219)
Other income, net:    
Interest and other income, net 2,842 3,858
Total other income, net 2,842 3,858
Loss before income taxes (26,322) (28,361)
Net loss $ (26,322) $ (28,361)
Net loss per share − basic (in dollars per share) $ (0.37) $ (0.41)
Net loss per share − diluted (in dollars per share) $ (0.37) $ (0.41)
Weighted-average number of shares used in computed net loss per share − basic 70,833,044 68,432,168
Weighted-average number of shares used in computed net loss per share − diluted 70,833,044 68,432,168
Other comprehensive income (loss)    
Unrealized loss on marketable securities $ (10) $ (253)
Comprehensive loss $ (26,332) $ (28,614)
Revenue from Contract with Customer, Product and Service [Extensible Enumeration] Collaborative Arrangement [Member] Collaborative Arrangement [Member]